In 70s, it had been confirmed that HHT had favorably therapeutic activity in patients with acute myelogenous leukemia (AML) and chronic myelogenous leukemia (CML).

• 我国在70年代将其用于急性非淋巴细胞白血病(AML)和慢性粒细胞白血病(CML)的治疗取得良好疗效。